Induction of vascular atrophy as a novel approach to treating restenosis. A review

Journal of Vascular Surgery

Volumn 47, Issue 3, 2008, Pages 662-670

  Min, Seung Kee ^a   Kenagy, Richard D ^b   Clowes, Alexander W ^b  

^a Seoul National University College of Medicine   (South Korea)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; ENALAPRIL; IMATINIB; LOSARTAN; NIFEDIPINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RAPAMYCIN; ZINC FINGER PROTEIN;

ALLOTRANSPLANTATION; ARTERY INTIMA PROLIFERATION; ATROPHY; BLOOD FLOW; BLOOD VESSEL GRAFT; BYPASS SURGERY; CELL DEATH; DRUG MECHANISM; EXTRACELLULAR MATRIX; HUMAN; HYPERTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTENOSIS; REVIEW; STENOSIS;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ATROPHY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; BLOOD VESSELS; CARDIOVASCULAR AGENTS; CELL DEATH; CELL PROLIFERATION; CONSTRICTION, PATHOLOGIC; CORONARY DISEASE; DISEASE MODELS, ANIMAL; HEART TRANSPLANTATION; HUMANS; HYPERPLASIA; HYPERTENSION; HYPERTROPHY; RECURRENCE; REMISSION INDUCTION; SIGNAL TRANSDUCTION; STENTS;

EID: 39149130737     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.07.056     Document Type: Review

References (114)

1. Bauters C., and Isner J.M. The biology of restenosis. Prog Cardiovasc Dis 40 (1997) 107-116
2. Kester M., Waybill P., and Kozak M. New strategies to prevent restenosis. Am J Cardiovasc Drugs 1 (2001) 77-83
3. Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
4. Mitra A.K., Gangahar D.M., and Agrawal D.K. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 84 (2006) 115-124
5. Allaire E., and Clowes A.W. Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg 63 (1997) 582-591
6. Fingerle J., Au Y.P.T., Clowes A.W., and Reidy M.A. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 10 (1990) 1082-1087
7. Beohar N., Flaherty J.D., Davidson C.J., Maynard R.C., Robbins J.D., Shah A.P., et al. Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury model. Circulation 109 (2004) 108-113
8. Clarke M.C., Figg N., Maguire J.J., Davenport A.P., Goddard M., Littlewood T.D., et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12 (2006) 1075-1080
9. Clowes A.W., Reidy M.A., and Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49 (1983) 327-333
10. Lindner V., Lappi D.A., Baird A., Majack R.A., and Reidy M.A. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68 (1991) 106-113
11. Olson N.E., Chao S., Lindner V., and Reidy M.A. Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol 140 (1992) 1017-1023
12. Lewis C.D., Olson N.E., Raines E.W., Reidy M.A., and Jackson C.L. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets 12 (2001) 352-358
13. Englesbe M.J., Davies M.G., Hawkins S.M., Hsieh P.C.H., Daum G., Kenagy R.D., et al. Arterial injury repair in nonhuman primates: the role of platelet-derived growth factor receptor-b. J Surg Res 119 (2004) 80-84
14. Hayry P., Myllarniemi M., Aavik E., Alatalo S., Aho P., Yilmaz S., et al. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 9 (1995) 1336-1344
15. Zhu B.H., Zhao G.S., Witte D.P., Hui D.Y., and Fagin J.A. Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intra-arterial injury. Endocrinology 142 (2001) 3598-3606
16. Gallo R., Padurean A., Toschi V., Bichler J., and Fallon J.T. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 97 (1998) 588
17. Wolf Y.G., Rasmussen L.M., and Ruoslahti E. Antibodies against transforming growth factor-b1 suppress intimal hyperplasia in a rat model. J Clin Invest 93 (1994) 1172-1178
18. Rectenwald J.E., Moldawer L.L., Huber T.S., Seeger J.M., and Ozaki C.K. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102 (2000) 1697-1702
19. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277 (2002) 37487-37491
20. Tran P.K., Tran-Lundmark K., Soininen R., Tryggvason K., Thyberg J., and Hedin U. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res 94 (2004) 550-558
21. Fukai N., Kenagy R.D., Daum G., Li Q., Parks W.C., and Clowes A.W. Syndecan-1 inhibits the development of intimal thickening after vascular injury. FASEB J 21 6 part II (2007) A746
22. Feldman L.J., Aguirre L., Ziol M., Bridou J.P., Nevo N., Michel J.B., and Steg P.G. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 101 (2000) 908-916
23. Rauma-Pinola T., Paakko P., Ilves M., Serpi R., Romppanen H., Vuolteenaho O., et al. Adrenomedullin gene transfer induces neointimal apoptosis and inhibits neointimal hyperplasia in injured rat artery. J Gene Med 8 (2006) 452-458
24. Aavik E., Luoto N.M., Petrov L., Aavik S., Patel Y.C., and Hayry P. Elimination of vascular fibrointimal hyperplasia by somatostatin receptor 1.4 selective agonist. FASEB Journal 16 (2002) NIL202-NIL223
25. Qin F., Dardik H., Pangilinan A., Robinson J., Chuy J., and Wengerter K. Remodeling and suppression of intimal hyperplasia of vascular grafts with a distal arteriovenous fistula in a rat model. J Vasc Surg 34 (2001) 701-706
26. Kohler T.R., and Jawien A. Flow affects development of intimal hyperplasia after arterial injury in rats. Arterioscler Thromb 12 (1992) 963-971
27. Jackson C.L., Raines E.W., Ross R., and Reidy M.A. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 13 (1993) 1218-1226
28. Englesbe M.J., Davies M.G., Hawkins S.M., Hsieh P.C.H., Daum G., Kenagy R.D., et al. Arterial injury repair in nonhuman primates: the role of PDGF receptor-b. J Surg Res 119 (2004) 80-84
29. Majesky M., Reidy M., Benditt E.P., and Schwartz S. Expression of platelet-derived growth factor (PDGF) A- and B-chain gene in smooth muscle during repair of arterial injury. J Mole Cell Cardiol 19 Suppl IV (1987) S3
30. Indolfi C., Torella D., Cavuto L., Davalli A.M., Coppola C., Esposito G., et al. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103 (2001) 2980-2986
31. Roqué M., Reis E.D., Fuster V., Padurean A., Fallon J.T., Taubman M.B., et al. Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. J Am Coll Cardiol 36 (2000) 2303-2310
32. Jackson C.L., and Reidy M.A. Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol 143 (1993) 1024-1031
33. Zalewski A., Shi Y., and Johnson A.G. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?. Circ Res 91 (2002) 652-655
34. Yokote K., Take A., Nakaseko C., Kobayashi K., Fujimoto M., Kawamura H., et al. Bone marrow-derived vascular cells in response to injury. J Atheroscler Thromb 10 (2003) 205-210
35. Nikkari S.T., Järveläinen H.T., Wight T.N., Ferguson M., and Clowes A.W. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 144 (1994) 1348-1356
36. Koyama H., and Reidy M.A. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res 80 (1997) 408-417
37. Koyama H., and Reidy M.A. Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. Circ Res 82 (1998) 988-995
38. Hanke H., Strohschneider T., Oberhoff M., Betz E., and Karsch K.R. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 67 (1990) 651-659
39. Dimmeler S., and Zeiher A.M. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87 (2000) 434-439
40. Im E., and Kazlauskas A. New insights regarding vessel regression. Cell Cycle 5 (2006) 2057-2059
41. Langille B.L., and O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231 (1986) 405-407
42. Cho A., Courtman D.W., and Langille B.L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 76 (1995) 168-175
43. Lobov I.B., Rao S., Carroll T.J., Vallance J.E., Ito M., Ondr J.K., et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437 (2005) 417-421
44. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
45. Chrétien M., Noria S.F., Jackson M., and Langille B.L. Vascular adaptations to altered blood flow. In: Colman R.W., Marder V.J., Clowes A.W., George J.N., and Goldhaber S.Z. (Eds). Hemostasis and thrombosis: basic principles and clinical practice (2006), Lippincott Williams and Wilkins, Philadelphia 667-678
46. Im E., and Kazlauskas A. Regulating angiogenesis at the level of PtdIns-4,5-P2. EMBO J 25 (2006) 2075-2082
47. Im E., Venkatakrishnan A., and Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 16 (2005) 3488-3500
48. Carmeliet P. Manipulating angiogenesis in medicine. J Intern Med 255 (2004) 538-561
49. Clowes A.W., Kirkman T.R., and Reidy M.A. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am J Pathol 123 (1986) 220-230
50. Mattsson E.J.R., Kohler T.R., Vergel S.M., and Clowes A.W. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 17 (1997) 2245-2249
51. Berceli S.A., Davies M.G., Kenagy R.D., and Clowes A.W. Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg 36 (2002) 1248-1255
52. Hsieh P.C.H., Kenagy R.D., Mulvihill E.R., Jeanette J.P., Wang X., Chang C.M.C., et al. Bone morphogenetic protein 4: Potential regulator of shear stress-induced graft neointimal atrophy. J Vasc Surg 43 (2006) 150-158
53. Kenagy R.D., Fischer J.W., Lara S., Sandy J.D., Clowes A.W., and Wight T.N. Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem 53 (2005) 131-140
54. Kenagy R.D., Fischer J.W., Davies M.G., Berceli S.A., Hawkins S.M., Wight T.N., et al. Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol 22 (2002) 400-404
55. Quan A., Ward M.E., Kulandavelu S., Adamson S.L., and Langille B.L. Endothelium-independent flow-induced dilation in the mouse carotid artery. J Vasc Res 43 (2006) 383-391
56. Zhuang Y.-J., Singh T.M., Zarins C.K., and Masuda H. Sequential increases and decreases in blood flow stimulates progressive intimal thickening. Eur J Vasc Endovasc Surg 16 (1998) 301-310
57. Peyton K.J., Reyna S.V., Chapman G.B., Ensenat D., Liu X.M., Wang H., et al. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99 (2002) 4443-4448
58. Kohler T.R., Kirkman T.R., and Clowes A.W. The effect of rigid external support on vein graft adaptation to the arterial circulation. J Vasc Surg 9 (1989) 277-285
59. Courtman D.W., Cho A., Langille L., and Wilson G.J. Eliminating arterial pulsatile strain by external banding induces medial but not neointimal atrophy and apoptosis in the rabbit. Am J Pathol 153 (1998) 1723-1729
60. Bayer I.M., Adamson S.L., and Langille B.L. Atrophic remodeling of the artery-cuffed artery. Arterioscler Thromb Vasc Biol 19 (1999) 1499-1505
61. Kenagy R.D., Jeanette J.P., Min S.-K., and Clowes A.W. Effects of wall tension and blood flow on cuff-induced atrophy of the baboon iliac artery. Arterioscler ThrombVasc Biol 26 (2006) e77 Abstract
62. Davies M.G., Klyachkin M.L., Dalen H., Svendsen E., and Hagen P.-O. Regression of intimal hyperplasia with restoration of endothelium- dependent relaxing factor-mediated relaxation in experimental vein grafts. Surgery 114 (1993) 258-271
63. Davies M.G., Fulton G.J., Svendsen E., and Hagen P.O. Time course of the regression of intimal hyperplasia in experimental vein grafts. Cardiovasc Pathol 8 (1999) 161-168
64. Kuroda N., Kobayashi Y., Nameki M., Kuriyama N., Kinoshita T., Okuno T., et al. Intimal hyperplasia regression from 6 to 12 months after stenting. Am J Cardiol 89 (2002) 869-872
65. Asakura M., Ueda Y., Nanto S., Hirayama A., Adachi T., Kitakaze M., et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation 97 (1998) 2003-2006
66. Kim W.H., Hong M.K., Virmani R., Kornowski R., Jones R., and Leon M.B. Histopathologic analysis of in-stent neointimal regression in a porcine coronary model. Coron Artery Dis 11 (2000) 273-277
67. Finn A.V., Gold H.K., Tang A., Weber D.K., Wight T.N., Clermont A., et al. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res 39 (2002) 414-425
68. Farb A., Kolodgie F.D., Hwang J.Y., Burke A.P., Tefera K., Weber D.K., et al. Extracellular matrix changes in stented human coronary arteries. Circulation 110 (2004) 940-947
69. Hong M.K., Lee C.W., Kim Y.H., Lee B.K., Kim M.K., Yang T.H., et al. Two-year follow-up intravascular ultrasound analysis after bare metal stent implantation in 120 lesions. Catheter Cardiovasc Interv 65 (2005) 247-253
70. Clowes A.W., Reidy M.A., and Clowes M.M. Mechanisms of stenosis after arterial injury. Lab Invest 49 (1983) 208-215
71. Nuthakki V.K., Fleser P.S., Malinzak L.E., Seymour M.L., Callahan R.E., Bendick P.J., et al. Lysyl oxidase expression in a rat model of arterial balloon injury. J Vasc Surg 40 (2004) 123-129
72. Fleischmann E.H., and Schmieder R.E. Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy?. Curr Cardiol Rep 4 (2002) 474-478
73. DeBlois D., Tea B.S., Beaudry D., and Hamet P. Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage. Can J Physiol Pharmacol 83 (2005) 29-41
74. DeBlois D., Tea B.S., Than V.D., Tremblay J., and Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 29 (1997) 340-349
75. Schiffrin E.L., and Deng L.Y. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens 14 (1996) 1247-1255
76. Lemay J., Tea B.S., Hamet P., and DeBlois D. Regression of neointimal lesions in the carotid artery of nifedipine-treated SHR and WKY rats: possible role of apoptosis. J Vasc Res 38 (2001) 462-470
77. DeBlois D., Orlov S.N., and Hamet P. Apoptosis in cardiovascular remodeling-effect of medication. Cardiovasc Drugs Ther 15 (2001) 539-545
78. Mandegar M., Fung Y.C., Huang W., Remillard C.V., Rubin L.J., and Yuan J.X. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 68 (2004) 75-103
79. Said S.I. Mediators and modulators of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 291 (2006) L547-L558
80. Cowan K.N., Jones P.L., and Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105 (2000) 21-34
81. Merklinger S.L., Jones P.L., Martinez E.C., and Rabinovitch M. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 112 (2005) 423-431
82. Cowan K.N., Heilbut A., Humpl T., Lam C., Ito S., and Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6 (2000) 698-702
83. O'Blenes S.B., Fischer S., McIntyre B., Keshavjee S., and Rabinovitch M. Hemodynamic unloading leads to regression of pulmonary vascular disease in rats. J Thorac Cardiovasc Surg 121 (2001) 279-289
84. Schermuly R.T., Dony E., Ghofrani H.A., Pullamsetti S., Savai R., Roth M., et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115 (2005) 2811-2821
85. Ghofrani H.A., Seeger W., and Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 353 (2005) 1412-1413
86. Patterson K.C., Weissmann A., Ahmadi T., and Farber H.W. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 145 (2006) 152-153
87. Fabian M.A., Biggs III W.H., Treiber D.K., Atteridge C.E., Azimioara M.D., Benedetti M.G., et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23 (2005) 329-336
88. Mehra M.R. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant 6 (2006) 1248-1256
89. Rahmani M., Cruz R.P., Granville D.J., and McManus B.M. Allograft vasculopathy versus atherosclerosis. Circ Res 99 (2006) 801-815
90. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196-204
91. Ferran C. Protective genes in the vessel wall: Modulators of graft survival and function. Transplantation 82 (2006) S36-S40
92. Sihvola R.K., Tikkanen J.M., Krebs R., Aaltola E.M., Buchdunger E., Laitinen O., et al. Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits. Transplantation 75 (2003) 334-339
93. Nykanen A.I., Krebs R., Tikkanen J.M., Raisky O., Sihvola R., Wood J., et al. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 79 (2005) 182-189
94. Savikko J., Taskinen E., and von Willebrand E. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Transplantation 75 (2003) 1147-1153
95. Koltin Y., Faucette L., Bergsma D.J., Levy M.A., Cafferkey R., et al. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol Cell Biol 11 (1991) 1718-1723
96. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
97. Luo Y., Marx S.O., Kiyokawa H., Koff A., Massague J., and Marks A.R. Rapamycin resistance tied to defective regulation of p27Kip1. Mol Cell Biol 16 (1996) 6744-6751
98. Nourse J., Firpo E., Flanagan W.M., Coats S., Polyak K., Lee M.H., et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 (1994) 570-573
99. Marks A.R. Sirolimus for the prevention of in-stent restenosis in a coronary artery. N Engl J Med 349 (2003) 1307-1309
100. Parry T.J., Brosius R., Thyagarajan R., Carter D., Argentieri D., Falotico R., et al. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. Eur J Pharmacol 524 (2005) 19-29
101. Gustafsson F., and Ross H.J. Proliferation signal inhibitors in cardiac transplantation. Curr Opin Cardiol 22 (2007) 111-116
102. Ruygrok P.N., Webber B., Faddy S., Muller D.W., and Keogh A. Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression. J Heart Lung Transplant 22 (2003) 1276-1279
103. Park J.W., Merz M., and Braun P. Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis. J Heart Lung Transplant 16 (1997) 290-297
104. Tanizawa S., Ueda M., Van der Loos C.M., Van Der Wal A.C., and Becker A.E. Expression of platelet derived growth factor B chain and b receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Br Heart J 75 (1996) 549-556
105. Ueda M., Becker A.E., Kasayuki N., Kojima A., Morita Y., and Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol 149 (1996) 831-843
106. Davies M.G., Owens E.L., Mason D.P., Lea H., Tran P.K., Vergel S., et al. Effect of platelet-derived growth factor receptor-a and -b blockade on flow-induced neointimal formation in endothelialized baboon vascular grafts. Circ Res 86 (2000) 779-786
107. Bennett M.R., Evan G.I., and Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 95 (1995) 2266-2274
108. Englesbe M.J., Hawkins S., Hsieh P.C.H., Davies M.G., Daum G., Kenagy R.D., et al. Concomitant blockade of PDGF receptors -a and -b induces intimal atrophy in baboon PTFE grafts. J Vasc Surg 39 (2004) 440-446
109. Serruys P.W., Heyndrickx G.R., Patel J., Cummins P.A., Kleijne J.A., and Clowes A.W. Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement. Int J Cardiovasc Intervent 5 (2003) 214-222
110. Beyaert R., Heyninck K., and Van Huffel S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem Pharmacol 60 (2000) 1143-1151
111. Patel V.I., Daniel S., Longo C.R., Shrikhande G.V., Scali S.T., Czismadia E., et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J 20 (2006) 1418-1430
112. Daniel S., Arvelo M.B., Patel V.I., Longo C.R., Shrikhande G., Shukri T., et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 104 (2004) 2376-2384
113. Min S.-K., Defawe O., Kenagy R.D., Mulvihill E.R., and Clowes A.W. ADAMTS4, tissue plasminogen activator, and hyaluronidase 2 are upregulated while GAS6 is downregulated in two baboon vascular atrophy models. FASEB J 21 6 part II (2007) A1128
114. Bavry A.A., Chiu J.H., Jefferson B.K., Karha J., Bhatt D.L., Ellis S.G., et al. Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med 146 (2007) 230-232